Hepatic cavernous hemangioma: Underrecognized associated histologic features

Liver International

Volumn 26, Issue 3, 2006, Pages 334-338

  Kim, Grace E ^a   Thung, Swan N ^b   Tsui, Wilson M S ^c   Ferrell, Linda D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c Caritas Medical Centre Hong Kong   (Hong Kong)

Author keywords

Cavernous hemangioma; Giant hemangioma; Hepatic hemangioma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 4; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; CAVERNOUS HEMANGIOMA; CELL PROLIFERATION; DISEASE ASSOCIATION; ELASTIC FIBER; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER PARENCHYMA; LIVER RESECTION; LIVER TUMOR; MALE; SMOOTH MUSCLE; STAINING; VASODILATATION;

ADULT; AGED; AGED, 80 AND OVER; ENDOTHELIAL CELLS; FEMALE; HEMANGIOMA, CAVERNOUS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 33644806816     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01226.x     Document Type: Article

References (11)

1. Ishak K G, Goodman Z D, Stocker J T. Benign mesenchymal tumors and pseudotumors. In: Rosai J, Sobin LH, eds. Atlas of Tumor Pathology: Tumors of the Liver and Intrahepatic Bile Ducts. Third Series. Washington, DC: Armed Forces Institute of Pathology, 2001; 87-92.
2. Zimmermann A, Baer H U. Fibrous tumor-liver interface in large hepatic neoplasms: Its significance for tumor resection and enucleation. Liver Transplant Surg 1996; 2: 192-9.
3. Cheng-Xiang D. Hepatic cavernous hemangiomas. Chin Med J 1992; 105: 771-4.
4. Adam Y G, Huvos A G, Fortner J G. Giant hemangiomas of the liver. Ann Surg 1970; 172: 239-45.
5. Anthony P P. Tumours and tumour-like lesions of the liver and biliary tract: Aetiology, epidemiology and pathology. In: MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP, eds. Pathology of the Liver, 4th edn. New York: Churchill Livingstone, 2002; 748-9.
6. Lee R G. Diagnostic Liver Pathology. St. Louis, MO: Mosby, 1994; 462-4.
7. Moreno E A, Del Pozo R M, Vicente C M, Abellan A J. Indications for surgery in the treatment of hepatic hemangioma. Hepatogastroenterology 1996; 43: 422-6.
8. Ishak K G, Anthony P P, Niederau C, Nakanuma Y. Mesenchymal tumours of the liver. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of the Digestive System. Lyon, France: IARC Press, 2000; 191-8.
9. Makhlouf H R, Ishak K G. Sclerosed hemangioma and sclerosing cavernous hemangioma of the liver: A comparative clinicopathologic and immunohistochemical study with emphasis on the role of mast cells in their histogenesis. Liver 2002; 22: 70-8.
10. Daly J J, Schiller A L. The liver in hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 1976; 60: 723-6.
11. Garcia-Tsao G, Korzenik J R, Young L, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000; 343: 931-6.